RxDoctor Payments Data

Richard Yung, MD

Facial Plastic Surgery · White Plains, NYNPI 1528007168

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.7% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by GSK at 27.6% of the total.

$2,574in general payments, 2019–2025

Across 101 payments — averaging $25.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$710
  • Optinose US, Inc.$495
  • Novartis$303
  • Inspire Medical Systems, Inc.$240
  • Stryker$156
  • Acclarent, Inc$142
  • plus $527 from 12 others

What the payments were for

  • Food & beverage$2,54099%
  • Education$341%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,574 in reported general payments places this provider in the 65th percentile of 48 facial plastic surgery providers in New York.

See all facial plastic surgery providers in New York

Medicare billing

Part B allowed, 2024
$279,158
Medicare patients
450
Services billed
1,865

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide186$7,220
Fluticasone Propionate315$5,281
Famotidine323$4,672
Montelukast Sodium244$3,400
Azelastine Hcl81$3,321
Dexlansoprazole DrDexlansoprazole12$3,074
Olopatadine Hcl13$2,787
Mometasone Furoate20$2,255
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth16$1,724
Prednisolone Acetate41$1,083
Omeprazole69$1,038
Cefdinir45$749
Desloratadine13$690
Methylprednisolone103$645
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav65$526

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in White Plains

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →